Key statistics dashboard for Connect Biopharma Holdings Limited (CNTB). Valuation multiples (P/E, P/B, EV/EBITDA), profitability margins, financial-health ratios, per-share metrics and stock-level data in one consolidated view — the snapshot quantitative analysts and value investors check first.
Connect Biopharma Holdings Limited is a clinical-stage biopharmaceutical company dedicated to discovering and advancing immune modulators. Its primary objective is to develop treatments for serious autoimmune diseases and various inflammatory conditions. The company's lead investigational therapy is CBP-201, an anti-interleukin-4 receptor alpha antibody.
Stock Data
| Price | $1.24 |
| Market Cap | $78M |
| Enterprise Value | $51.7M |
| Beta | -0.21 |
| Exchange | NASDAQ |
| Country | US |
Valuation Multiples
| P/E Ratio | -1.41 |
| Price / Book | 2.90 |
| P/S | 26.58 |
| EV/EBITDA | -1.00 |
| EV/Sales | 17.59 |
| EV/FCF | -1.62 |
| P/FCF | -2.45 |
| Earnings Yield | -66.42% |
| FCF Yield | -40.89% |
| Dividend Yield | 0.00% |
Profitability
| Gross Margin | 100.00% |
| EBIT Margin | -1780.49% |
| EBITDA Margin | -1763.26% |
| Operating Margin | -1795.61% |
| Net Margin | -1763.40% |
| Return on Equity | -150.47% |
| Return on Assets | -119.14% |
| Return on Invested Capital | -191.33% |
| Return on Capital Employed | -194.09% |
Financial Health
| Current Ratio | 2.37 |
| Quick Ratio | 2.37 |
| Cash Ratio | 1.66 |
| Debt / Equity | 0.02 |
| Debt / Assets | 1.37% |
| Net Debt / EBITDA | 0.51 |
| Interest Coverage | 0.00 |
| Piotroski F-Score | 1 |
| Altman Z-Score | -5.94 |
Per-Share Data
| Revenue per share | 0.05 |
| Book Value per share | 0.43 |
| Cash per share | 0.50 |
| FCF per share | -0.51 |
| Tangible Book Value per share | 0.43 |
| Dividend per share | 0.00 |
Analyst Consensus
| Strong Buy | 0 |
| Buy | 5 |
| Hold | 0 |
| Sell | 0 |
| Strong Sell | 0 |
| Total analysts | 5 |
| Avg rating (1-5) | 1.00 |
Related companies: ARTV · CNTX · IFRX · IMA · KLRS · MGX · OVID
Explore sector: Healthcare · Biotechnology
More sections of CNTB: Overview · Financials · Valuation · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks